PHARMACOSMOS A/S: Financial statements 2018
CVR: 15517085
Source: annual report 2018, Danish Business Authority
01/05/2017 – 30/04/2018
PHARMACOSMOS A/S (CVR 15517085) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 542,240,000 and a net result of DKK 69,125,000 compared with DKK 158,715,000 the year before. That is an increase of 6% compared with the year before. The profit margin was 12.7%. Equity in the 2018 report amounted to DKK 720,762,000. The solvency ratio was 62%. The company had 208 employees in the financial year.
- Revenue
- DKK 542,240,000
- Gross Profit
- DKK 314,490,000
- Profit/Loss
- DKK 69,125,000
- Equity
- DKK 720,762,000
- Total Assets
- DKK 1,161,615,000
- Employees
- 208
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 542.2 mio. | 314.5 mio. | 69.1 mio. | 720.8 mio. | 208 |
| 2017 | 511.6 mio. | 314.8 mio. | 158.7 mio. | 656.8 mio. | 172 |
| 2016 | 448 mio. | 254.5 mio. | 102.7 mio. | 547.7 mio. | 111 |
| 2015 | - | 208.8 mio. | 81.1 mio. | 496.9 mio. | 105 |
| 2014 | - | 109.9 mio. | 6.2 mio. | 394.8 mio. | 105 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout PHARMACOSMOS A/S
PHARMACOSMOS A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1991. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named PHARMACOSMOS PHARMACEUTICALS A/S and SOLOCHEM A/S. The management consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker. The board consists of Jacob Tolstrup (chair), Lars Christensen, Lars Green and Martin Holst Lange. The company is owned by PHARMACOSMOS HOLDING A/S. The company has 327 employees (2026). In 2026, the company reported revenue of DKK 2,176,000,000 and a net result of DKK 714,000,000 compared with DKK 1,622,000,000 the year before. Equity in the 2026 report amounted to DKK 2,775,000,000.